Analysis of Debt
Total Debt (Carrying Amount)
GlaxoSmithKline PLC, balance sheet: debt
US$ in millions, translated from GBP £
Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).
| Debt item | Description | The company |
|---|---|---|
| Total borrowings (carrying amount) | Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. | GlaxoSmithKline PLC total debt increased from 2012 to 2013 and from 2013 to 2014. |
Total Debt (Fair Value)
| Dec 31, 2014 | |
|---|---|
| Selected Financial Data (US$ in millions, translated from GBP £) | |
| Total borrowings (fair value) | 35,763) |
| Financial Ratio | |
| Debt, fair value to carrying amount ratio | 1.13 |
Based on: 20-F (reporting date: 2014-12-31).
Weighted-average Interest Rate on Debt
Weighted-average effective interest rate on borrowings: 3.68%
| Interest rate | Debt amount1 | Interest rate × Debt amount | Weighted-average interest rate2 |
|---|---|---|---|
| 4.28% | 379) | 16) | |
| 0.22% | 656) | 1) | |
| 3.80% | 17,664) | 671) | |
| Total | 18,699) | 689) | |
| 3.68% | |||
Based on: 20-F (reporting date: 2014-12-31).
1 GBP £ in millions
2 Weighted-average interest rate = 100 × 689 ÷ 18,699 = 3.68%